Florida Telehealth Rules for Mental Health and Addiction Treatment

Florida Statute 456.47 requires all telehealth providers to register with the Florida Department of Health before delivering telehealth services to patients located in Florida. The statute applies to Florida-licensed providers and out-of-state providers who treat Florida patients remotely. Out-of-state providers must register as Florida telehealth providers and maintain an active, unencumbered license in their home state.

Key requirements under Florida Statute 456.47:

• Registration: all telehealth providers must register with the Florida Department of Health through the online telehealth provider registry; registration is free and separate from Florida licensure
• Standard of care: telehealth providers must deliver the same standard of care as in-person services; Florida law does not create a separate or lower standard for telehealth
• Patient location: the patient must be located in Florida at the time of the telehealth encounter for Florida telehealth law to apply
• Technology requirements: telehealth must be delivered through real-time audio-video communication (synchronous) or store-and-forward technology (asynchronous); audio-only telephone calls qualify as telehealth in Florida under the 2021 amendment to 456.47
• Medical records: telehealth encounters require the same documentation standards as in-person encounters under Florida Statute 456.057

Florida-licensed mental health professionals including licensed clinical social workers (LCSWs), licensed mental health counselors (LMHCs), licensed marriage and family therapists (LMFTs), psychologists, and psychiatrists provide telehealth services after completing the DOH registration. Certified addiction professionals (CAPs) deliver telehealth services within the scope of Florida Administrative Code 65D-30.

Florida Statute 456.47(4) requires telehealth providers to obtain informed consent from the patient before initiating a telehealth encounter. The informed consent must be documented in the patient's medical record. Florida does not require a specific informed consent form but mandates that the consent cover specific elements.

Required elements of Florida telehealth informed consent:

• The patient understands the nature of telehealth services and the difference from in-person services
• The patient acknowledges potential risks of telehealth including technology failures, privacy limitations, and the possibility of misdiagnosis
• The patient understands the right to refuse telehealth and receive in-person services
• The patient acknowledges that telehealth encounters are subject to the same confidentiality protections as in-person encounters under Florida Statute 456.057 and HIPAA
• The patient confirms identity and physical location at the time of the encounter

For addiction treatment telehealth services, additional informed consent requirements apply under 42 CFR Part 2, the federal regulations governing confidentiality of substance use disorder patient records. 42 CFR Part 2 restricts disclosure of substance use disorder treatment information more strictly than HIPAA, requiring specific written consent for any disclosure outside the treatment program. Florida telehealth providers delivering substance use disorder treatment must comply with both Florida informed consent requirements and 42 CFR Part 2 consent requirements.

Florida telehealth providers can prescribe controlled substances through telehealth if the provider conducts a synchronous audio-video examination and complies with the Ryan Haight Online Pharmacy Consumer Protection Act. The Ryan Haight Act (21 U.S.C. 829(e)) generally requires at least one in-person medical evaluation before prescribing controlled substances via telemedicine, with specific exceptions for DEA-registered practitioners.

Florida telehealth controlled substance prescribing rules:

• Schedule II-V controlled substances: Florida-licensed physicians and advanced practice registered nurses (APRNs) can prescribe controlled substances via telehealth after a synchronous audio-video encounter; the DEA requires a prior in-person evaluation under the Ryan Haight Act unless a public health emergency exception applies
• Buprenorphine (Schedule III): the DEA's post-pandemic telehealth flexibilities allow buprenorphine prescribing via audio-video telehealth for new patients without a prior in-person visit under the DEA's 2024 Temporary Rule extension; patients who began buprenorphine via telehealth must complete an in-person evaluation within 12 months
• Methadone: methadone for opioid use disorder can only be dispensed through SAMHSA-certified opioid treatment programs (OTPs); telehealth is permitted for OTP counseling sessions but methadone dispensing requires in-person attendance at the OTP
• Stimulants (Schedule II): prescribing stimulants such as amphetamine for ADHD via telehealth requires a prior in-person evaluation under the Ryan Haight Act standard rules
• Benzodiazepines (Schedule IV): subject to the same Ryan Haight Act requirements as other controlled substances

Florida Statute 456.47 does not independently restrict controlled substance prescribing via telehealth beyond federal requirements. The Florida Board of Medicine requires telehealth prescribers to check the Florida Prescription Drug Monitoring Program (E-FORCSE) database before prescribing controlled substances, the same requirement that applies to in-person prescribing under Florida Statute 893.055.

Florida-licensed substance abuse treatment programs deliver telehealth services for outpatient counseling, intensive outpatient programs (IOP), and partial hospitalization programs (PHP) within the framework of Florida Administrative Code 65D-30. The Florida Department of Children and Families (DCF) permits telehealth delivery of individual counseling, group counseling, psychoeducation, and case management within licensed substance abuse treatment programs.

Telehealth applications by Florida treatment level of care:

Florida Medicaid managed care plans reimburse telehealth substance abuse treatment services at the same rate as in-person services for outpatient and IOP levels of care. Medicare also covers telehealth behavioral health services for Florida beneficiaries under the Medicare Telehealth Services expansion. Private insurers in Florida are required to reimburse telehealth services under Florida Statute 627.42396, though specific reimbursement rates vary by plan.

Florida Statute 627.42396 requires health insurers to cover telehealth services at the same reimbursement rate as equivalent in-person services when the service is medically necessary and provided by an in-network or authorized out-of-network provider. The statute applies to all health insurance policies and health maintenance organizations regulated by the Florida Office of Insurance Regulation.

Insurance coverage details for telehealth addiction treatment in Florida:

• Private insurance (commercial plans): Florida law requires coverage of telehealth at in-person rates; cost-sharing (copays, deductibles) can differ from in-person visits only if disclosed in the plan documents; most major Florida insurers (Florida Blue, Aetna, United, Cigna) cover telehealth IOP and outpatient counseling
• Florida Medicaid: Statewide Medicaid Managed Care plans cover telehealth behavioral health services at in-person rates; prior authorization requirements are the same for telehealth and in-person services
• Medicare: covers telehealth mental health and substance abuse services for Florida beneficiaries; the geographic restrictions on Medicare telehealth were permanently removed for behavioral health services under the Consolidated Appropriations Act of 2023
• TRICARE: covers telehealth behavioral health services for active-duty military, veterans, and dependents in Florida; no geographic restrictions

Insurers in Florida cannot require a prior in-person visit as a condition of telehealth coverage for behavioral health services. Florida Statute 627.42396 prohibits insurers from imposing requirements on telehealth services that are not imposed on the same in-person services. Verification of telehealth benefits is recommended before initiating treatment, as out-of-network telehealth providers may not be subject to the same coverage mandates.

Out-of-state health care providers must register with the Florida Department of Health as telehealth providers under Florida Statute 456.47(2)(a) before treating patients located in Florida. Out-of-state providers are not required to obtain a separate Florida license if the provider holds an active, unencumbered license in the provider's home state and registers through the Florida DOH telehealth registry.

Requirements for out-of-state telehealth providers treating Florida patients:

• Home state license: the provider must hold an active, unrestricted license in the provider's home state in a profession that is also licensed in Florida
• DOH registration: the provider must complete the Florida telehealth provider registration through the DOH online portal; registration is free
• Scope of practice: the provider's scope of practice is limited to the scope authorized by the provider's home state license or the Florida scope for the equivalent profession, whichever is more restrictive
• Malpractice coverage: the provider must maintain professional liability insurance that covers telehealth services delivered to Florida patients
• Prescribing: out-of-state telehealth providers who prescribe controlled substances to Florida patients must hold a Florida DEA registration or a DEA registration in the provider's home state that permits prescribing to Florida patients

Florida's telehealth registration exemption for out-of-state providers does not apply to providers treating patients in Florida on a temporary basis for less than 10 days per calendar year. Providers treating Florida patients for fewer than 10 days per year are exempt from both Florida licensure and telehealth registration under Florida Statute 456.47(2)(c). The Psychology Interjurisdictional Compact (PSYPACT) allows psychologists in PSYPACT member states (Florida is a PSYPACT member as of 2022) to practice telepsychology across state lines without additional registration.

Florida telehealth services must comply with HIPAA, 42 CFR Part 2 (for substance use disorder records), and Florida Statute 456.057 (patient medical records confidentiality). Telehealth platforms used by Florida providers must meet HIPAA security rule requirements for electronic protected health information (ePHI) including encryption, access controls, and audit logging.

Privacy and security requirements for Florida telehealth in addiction treatment:

• HIPAA compliance: all telehealth platforms must provide end-to-end encryption, business associate agreements (BAAs), and access controls compliant with 45 CFR Part 164
• 42 CFR Part 2: substance use disorder treatment records transmitted via telehealth are subject to the same federal confidentiality protections as in-person records; the 2024 final rule aligning 42 CFR Part 2 more closely with HIPAA does not eliminate the prohibition on re-disclosure of SUD records without patient consent
• Platform restrictions: Florida providers cannot use consumer-grade video platforms (such as FaceTime, Skype, or Zoom free tier) for telehealth unless the platform offers a HIPAA-compliant version with a BAA; approved platforms include Doxy.me, Zoom for Healthcare, Microsoft Teams for Healthcare, and proprietary EHR-integrated platforms
• Recording: Florida is a two-party consent state under Florida Statute 934.03; telehealth sessions cannot be recorded without the consent of all parties to the communication
• Data storage: telehealth session records, including video recordings if consented, must be stored in HIPAA-compliant systems and retained for the minimum period required by Florida Statute 456.057 (7 years for adults, 7 years after age 18 for minors)

The Florida Board of Medicine issued guidance in 2023 stating that artificial intelligence tools used in telehealth encounters (such as AI-generated clinical notes) must be disclosed to patients and documented in the medical record. AI-generated treatment recommendations must be reviewed and verified by the licensed provider before implementation.